← Back to headlines
Eli Lilly Gains as Medicare Expansion of GLP-1 Weight Loss Drugs Eases Pricing Concerns
Eli Lilly and Company (LLY) stock has risen due to the expansion of Medicare coverage for GLP-1 weight loss drugs, which has alleviated pricing concerns.
18 Feb, 15:13 — 18 Feb, 15:13
Sources
Showing 1 of 1 sources
